Literature DB >> 17409972

Increasing osteoblastic lesions as a manifestation of a major response to gefitinib.

David Garfield1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17409972

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC).

Authors:  Cyrille B Confavreux; Nicolas Girard; Jean-Baptiste Pialat; Pierre-Paul Bringuier; Mojgan Devouassoux-Shisheboran; Jean-Charles Rousseau; Sylvie Isaac; Françoise Thivolet-Bejui; Philippe Clezardin; Marie Brevet
Journal:  Bonekey Rep       Date:  2014-10-01

Review 2.  Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Authors:  Michael P Gabay; Scott M Wirth; Joan M Stachnik; Colleen L Overley; Katie E Long; Linda R Bressler; John L Villano
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

3.  Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC.

Authors:  David Rossi; Paolo Giordani; Paolo Alessandroni; Vincenzo Catalano; Virginia Casadei; Anna Maria Baldelli; Stefano Luzi Fedeli; Francesco Graziano; Giammaria Fiorentini
Journal:  World J Oncol       Date:  2012-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.